Showing 1 - 20 results of 54 for search '"Zhangzhou"', query time: 0.06s Refine Results
  1. 1

    Estimating the prevalence of six common respiratory viral infections in Zhangzhou, China using nasopharyngeal swabs in adults and throat swabs in Children by Yuanjun Zeng, Guowei Wang, Huicong Yang, Hongmei Li, Yueli Guo, Huili Liu, Xiaojun Xu, Chunbin Zhang

    Published 2025-01-01
    “…The study aimed to investigate the epidemiology of six common respiratory viral infections in Zhangzhou, Fujian Province, China. Clinical and demographic information, along with throat swabs from children and nasopharyngeal swabs from adults, were collected from 19,523 patients from Jan 2023 to Aug 2024 in Zhangzhou, Fujian Province, China. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Elevated Fasting C-Peptide Levels Correlate with Increased 10-Year Risk of Atherosclerotic Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes Patients by Zha XY, Wei CS, Dong JJ, Wu JZ, Xie LX, Xu ZH, Zheng HQ, Huang DB, Lai PB

    Published 2025-01-01
    “…Xiao-Yun Zha, Chang-Shun Wei, Jia-Jia Dong, Jin-Zhi Wu, Liang-Xiao Xie, Ze-Hong Xu, Hua-Qiang Zheng, Duo-Bin Huang, Peng-Bin Lai The First Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, 363000, People’s Republic of ChinaCorrespondence: Peng-Bin Lai, The First Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, 363000, People’s Republic of China, Tel +8613709398727, Email 13709398727@163.comPurpose: This study aims to analyze the impact of serum C-peptide levels in patients with newly diagnosed type 2 diabetes (T2DM) on the 10-year risk of atherosclerotic cardiovascular disease (ASCVD).Patients and Methods: A total of 1923 patients with newly diagnosed T2DM were selected and categorized into four groups based on the interquartile range of fasting C-peptide (FCP) levels: Q1 group (FCP≤ 0.568 ng/mL), Q2 group (0.568 < FCP≤ 0.751 ng/mL), Q3 group (0.751 < FCP≤ 0.980 ng/mL), and Q4 group (FCP > 0.980 ng/mL). …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20